TCL Archive Increase In DCCR Grants May Not Be Possible Without Decreasing Quality, Committee Told July 28, 1978
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive In Brief: FDA Changes Package Inserts For Thiotepa, Cyclophosphamide, As Committee Suggested August 31, 1979
